Cargando…

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis

PURPOSE: To describe the treatment results with adalimumab in chronic paediatric uveitis, not associated with juvenile idiopathic arthritis (JIA). METHODS: Medical records of children with non‐JIA‐uveitis were reviewed retrospectively. Children without an underlying systemic disease were pre‐screene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouwenberg, Carlyn V., Koopman‐Kalinina Ayuso, Viera, de Boer, Joke H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290889/ https://www.ncbi.nlm.nih.gov/pubmed/34532967 http://dx.doi.org/10.1111/aos.15012

Ejemplares similares

Involvement of the systemic microcirculation in pediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2023)

Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis
por: van Straalen, Joeri W, et al.
Publicado: (2023)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Improved clinical outcomes in patients with juvenile idiopathic arthritis associated uveitis in the last decade
por: Wennink, Roos A.W., et al.
Publicado: (2022)

A Blood Protein Signature Stratifies Clinical Response to csDMARD Therapy in Pediatric Uveitis
por: Wennink, Roos A. W., et al.
Publicado: (2022)

Evaluation of the JIA treatment with adalimumab in ukraine
por: Ponochevna, Elena, et al.
Publicado: (2014)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2020)

Next-Generation HLA Sequence Analysis Uncovers Shared Risk Alleles Between Clinically Distinct Forms of Childhood Uveitis
por: Wennink, Roos A. W., et al.
Publicado: (2021)

The swedish paediatric JIA-registry
por: Magnusson, Bo
Publicado: (2014)

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
por: Ho, Mary, et al.
Publicado: (2019)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

P66 Adalimumab originator versus biosimilar in children and young people with JIA
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2022)

Whole Transcriptome Analysis Reveals Heterogeneity in B Cell Memory Populations in Patients With Juvenile Idiopathic Arthritis-Associated Uveitis
por: Wennink, Roos A. W., et al.
Publicado: (2020)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Psychological Effects and Quality of Life in Parents and Children with Jia-Associated Uveitis
por: Guerriero, Silvana, et al.
Publicado: (2022)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

The use of Etanercept and Adalimumab in the management of JIA: a 5-year follow-up study
por: Trachana, M, et al.
Publicado: (2008)

The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
por: Davies, Rebecca, et al.
Publicado: (2020)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
por: Angeles-Han, Sheila T., et al.
Publicado: (2015)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort
por: Morelle, Guillaume, et al.
Publicado: (2019)

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
por: Marelli, Luca, et al.
Publicado: (2021)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series
por: La Torre, Francesco, et al.
Publicado: (2014)

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2018)

Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
por: Liu, Weishai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tm0uralon90kc4472bn8veqrmk